From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Exertional dyspnea)

Dyspnea, also called air hunger or shortness of breath, is a symptom of ME/CFS.

Prevalence[edit | edit source]

  • 1995, Katrina Berne, PhD, reported a prevalence of 30-70% for shortness of breath.[1]
  • 2001, In a Belgian study, 79.2% of patients meeting the Fukuda criteria and 83.5% of patients meeting the Holmes criteria, in a cohort of 2073 CFS patients, reported exertional dyspnea.[2]

Symptom recognition[edit | edit source]

  • Air hunger or labored breathing are also included in the criteria for diagnosis in the International Consensus Criteria, under Respiratory part of Energy production/transportation impairments.[4]

Shortness of breath is a potential symptom of Long COVID in the World Health Organization's definition.[6]

Notable studies[edit | edit source]

  • 2012, Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies.[7] - (Full Text)

Possible causes[edit | edit source]

Potential treatments[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. Berne, Katrina (December 1, 1995). Running on Empty: The Complete Guide to Chronic Fatigue Syndrome (CFIDS) (2nd ed.). Hunter House. p. 58. ISBN 978-0897931915.
  2. De Becker, Pascale; McGregor, Neil; De Meirleir, Kenny (December 2001). "A definition‐based analysis of symptoms in a large cohort of patients with chronic fatigue syndrome". Journal of Internal Medicine. 250 (3): 234–240. doi:10.1046/j.1365-2796.2001.00890.x.
  3. A Clinical Case Definition and Guidelines for Medical Practitioners: An Overview of the Canadian Consensus Document
  4. Carruthers, BM; van de Sande, MI; De Meirleir, KL; Klimas, NG; Broderick, G; Mitchell, T; Staines, D; Powles, ACP; Speight, N; Vallings, R; Bateman, L; Baumgarten-Austrheim, B; Bell, DS; Carlo-Stella, N; Chia, J; Darragh, A; Jo, D; Lewis, DP; Light, AR; Marshall-Gradisnik, S; Mena, I; Mikovits, JA; Miwa, K; Murovska, M; Pall, ML; Stevens, SR (August 22, 2011), "Myalgic encephalomyelitis: International Consensus Criteria", Journal of Internal Medicine, 270 (4): 327–338, doi:10.1111/j.1365-2796.2011.02428.x, PMID 21777306
  5. Institute of Medicine (2015). Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness. Washington, DC: The National Academies Press. doi:10.17226/19012. ISBN 0309316898. PMID 25695122.
  6. Soriano, Joan B.; Allan, Maya; Alsokhn, Carine; Alwan, Nisreen A.; Askie, Lisa; Davis, Hannah E.; Diaz, Janet V.; Dua, Tarun; de Groote, Wouter; Jakob, Robert; Lado, Marta; Marshall, John; Murthy, Srin; Preller, Jacobus; Relan, Pryanka; Schiess, Nicoline; Seahwag, Archana (October 6, 2021), A clinical case definition of post COVID-19 condition by a Delphi consensus, World Health Organization (WHO) clinical case definition working group on post COVID-19 condition, World Health Organization
  7. Ravindran, Murugan; Adewuyi, Oluwatoyin; Zheng, Yin; Rayhan, Rakib U.; Le, Uyenphuong; Timbol, Christian; Merck, Samantha; Esteitie, Rania; Read, Charles; Baraniuk, James (December 12, 2012). "Dyspnea in Chronic Fatigue Syndrome (CFS): Comparison of Two Prospective Cross-Sectional Studies". Global Journal of Health Science. 5 (2). doi:10.5539/gjhs.v5n2p94. ISSN 1916-9744.
  8. Johnson, Miriam J.; Currow, David C. (September 1, 2020). "Opioids for breathlessness: a narrative review". BMJ Supportive & Palliative Care. 10 (3): 287–295. doi:10.1136/bmjspcare-2020-002314. ISSN 2045-435X. PMID 32620683.